Breath of relief

NEW YORK — Homeopathic supplier King Bio currently is presenting a replacement alternative for patients still seeking relief for their minor asthma symptoms in its 
AsthmaCare product.


It’s the kind of new product launch that 
almost could prevent a cough-cold buyer 
from hyperventilating — though that is not an advertised indication on the product’s Drug Facts Label.That’s because at the top of the year, production of Primatene Mist — the 
inhaler that served as the branded identity for asthma sufferers seeking 
a self-care solution — was halted. 
Primatene Mist 
still is cycling through sales data and currently represents an almost $50 million sales opportunity for King Bio.